Trial Profile
A Study Comparing Efficacy Of First-Line-Regimens Containing Abacavir With Lamivudine (ABC/3TC) Or Tenofovir With Emtricitabine (TDF/FTC) In Patients With A High Viral Load.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2017
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/abacavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 24 Feb 2017 New trial record